MedPath

ARCAGY RESEARCH

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Platine, Avastin and OLAparib in 1st Line

Phase 3
Completed
Conditions
Ovarian Cancer
Interventions
Drug: Olaparib
Drug: Placebo
First Posted Date
2015-06-23
Last Posted Date
2022-08-02
Lead Sponsor
Arcagy Research
Target Recruit Count
806
Registration Number
NCT02477644
Locations
🇦🇹

Medical University of Innsbruck, Innsbruck, Austria

🇦🇹

Krankenhaus Hietzing, Vienna, Austria

🇧🇪

CHU Dinant Godinne, Yvoir, Belgium

and more 158 locations
© Copyright 2025. All Rights Reserved by MedPath